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A B S T R A C T
Yeasts are common etiologic agents of onychomycosis. This study reported a case of onychomycosis due to
Cryptococcus friedmannii (Naganishia friedmannii). This yeast was isolated of the right great toenail of 57-
year-old man. Microscopic examination of nail scrapings showed budding cells with thin capsule. Sequence
analyzes of the internal transcribed spacer regions was closely related to Cryptococcus friedmannii. The results
of susceptibility testing showed the Cryptococcus friedmannii to be sensitive to ﬂuconazole, itraconazole and
amphotericin B.
1. Introduction
Onychomycosis is a common nail infection due to yeasts and
ﬁlamentous fungi [1,2]. The uncommon fungi such as Trichosporon
mucoides [3] Aspergillus clavatus [4] and Cryptococcus spp. (basidio-
mycetous yeasts) [5] were reported as emerging pathogens of onycho-
mycosis.
The basidiomycetous yeasts are important in economic, agricultural
and medical problems [6]. Cryptococcus neoformans (Cr. neoformans)
was an important agent of cryptococcal infections in immunocompro-
mised patients and Cr. gatti is the major pathogen in the genus as well
[7,8]. However the reports of infections due to non-neoformans have
been increased [9]. The species of Cryptococcus genus have been
identiﬁed from diﬀerent environmental sources such as air, water, soil,
wood, and pigeon excreta. Cr. friedmannii was reported as a new
species of yeast from Antarctic in 1985 [10]. The other studies reported
that Cr. friedmannii isolated from Beringian and Icelandic soils which
were more vegetated. This kind of yeast was reported from soil of
Tabriz in Iran as well [11,12]. Cr. friedmannii and some of the yeast
species were isolated from the Atacama Desert, with high daily
temperature variations. Cr. friedmannii had ability to survive at
moderate to cold temperatures [13]. Cr. friedmannii has not been
reported as an agent of onychomycosis.
2. Case
A 57-year-old man was admitted to our department in October
2015 (at day 0) with distal subungual hyperkeratosis clinical type of
onychomycosis on the ﬁrst right toenail (Fig. 1). The patient did not
have disease like diabetes, psoriasis, immunodeﬁciencies or any
chronic disease. However, four months ago (at day – 4 months), the
patient had a history of ungueal trauma and small traumatic lesion was
emerged on toenail. Three direct microscopic examinations (at day 0)
of nail scrapings, with 20% potassium hydroxide revealed single or
budding yeast cells. Three nail specimens were cultured on sabourauds
dextrose agar plates with chloramphenicol (at day 0), and incubated at
20–25 °C, which were produced creamy and smooth colonies after a
few days (Fig. 2). The other fungi were not isolated. Microscopic
examinations (at day 7) of the colonies with Chinese ink were shown
single or budding cells with a thin capsule (Fig. 3). Also, lactophenol
cotton blue wet mount slide of colonies showed budding cells (Fig. 4).
For molecular identiﬁcation, the yeast was cultured on yeast extract
peptone dextrose agar and incubated at 20–25 °C.
Genomic DNA was extracted using Qiagen tissue kit (Germany) (at
day 11). The ITS1-5.8S-ITS2 region was ampliﬁed with ITS1 (TCC GTA
GGT GAA CCT GCG G) and ITS4 (TCC TCC GCT TAT TGA TAT GC)
universal primers by the following proﬁle: 98 °C (5 min), 40 cycles of
98 °C (30 s), annealing temperature 56 °C (30 s), and 72 °C (30 s),
followed by a ﬁnal extension of 72 °C (5 min). Ampliﬁcation of the
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isolate with ITS1 and ITS4 primers yielded 500 bp fragment (at day
11).
The PCR products were sequenced by Macrogen (Korea). Sequence
analyzes was compared with the reference sequences of GenBank
database using BLAST (basic local alignment search tool) (http://
www.ncbi.nlm.nih.gov/BLAST). Sequence analyzes was 100% related
to Cr. friedmannii (Naganishia friedmannii) with the accession
number KM243311.1 (at day 23). The sequence of the ITS region
was submitted to the GeneBank as the accession number KX268322
(Fig. 5).
The antifungal susceptibilities were conducted according to the
Clinical and Laboratory Standard Institute method (document M27-
S3). The susceptibility tests of Cr. friedmannii to ﬂuconazole,
Itraconazole and amphotericin B was determined at 72 h. The MICs
results revealed this isolate was susceptible to these drugs with MIC
values of 0.25, 0.125 and 0.25 μg/ml for ﬂuconazole, itraconazole and
amphotericin B, respectively (at day 30). The patient was treated with
oral itraconazole at the dosage of 200 mg daily. Three months later, the
symptoms of disease complete remission of the nail. Direct microscopic
examinations of nail scrapings with 20% potassium hydroxide had not
revealed single or budding yeast cells and culture of the nail sample
was negative.
3. Discussion
The yeast Cr. friedmannii was ﬁrst reported as a new species of
basidiomycetous yeast of Antarctic in 1985 [10]. The incidence of
infection due to non- Cr. neoformans has increased. This increased
may reveal enhanced immunocompromised patients with impaired
cell-mediated immunity, organ transplantation, diabetic patients, azole
prophylaxis, and etc [9]. Some of non- Cr. neoformans species, such as
Cr. laurentii, Cr. albidus, Cr. luteolus, Cr. uniguttulatus, Cr. curvatus
and Cr. humicola were reported as opportunistic pathogens over the
last few years [9,14]. A case of Cr. laurentii keratitis was reported in
diabetic patient with onychomycosis. Cultures of the nail and of the
contact lens have shown Cr. laurentii and Fusarium solani [15]. Three
species of Cryptococcus (Cr. albidus, Cr. uniguttulatus and Cr.
laurentii) were isolated of onychomycosis in type 2 diabetes mellitus
Fig. 1. Distal subungual thickening and hyperkeratosis of patient.
Fig. 2. Creamy and smooth colonies of Cr. friedmannii on sabourauds dextrose agar
plate with chloramphenicol.
Fig. 3. Budding cells with a thin capsule with Chinese ink wet mount (×400).
Fig. 4. Budding cells in lactophenol cotton blue wet mount slide of colonies (×400).
Fig. 5. The sequence of the ITS region was submitted to the GeneBank as the accession number KX268322.
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patients [5]. Also, Prothoteca spp was reported as the ﬁrst causative
agent of onychomycosis in Brazil which was the 3rd case in the world
[16]. The distribution of pathogens of onychomycosis is not uniform. It
is related to several factors such as geographical region and climatic
conditions. Furthermore, onychomycosis is related to the host ones
such as age, occupation, chronic diseases, nail care and lifestyle.
Deformity and pain in nails are caused by the fungi in onychomycosis.
Thus, aﬀected individuals may experience diﬃculties while walking and
writing. Therefore, accurate diagnosis of the agents is important for
suitable therapeutic approach. This study reports Cr. friedmannii is the
ﬁrst case of onychomycosis in the world.
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